Agilent Technologies has announced that Merck-Serono has selected the Openlab electronic laboratory notebook (ELN) for biology research.
Merck-Serono, a division of Merck KGaA, is using the Openlab ELN to enhance scientific collaboration globally throughout research and development for finding new small molecules and biopharmaceuticals.
Approximately 600 Merck-Serono biology researchers at facilities in Geneva, Darmstadt and Boston will be using the ELN to collaborate on research projects.
Openlab ELN features the ability to design and customise experiment templates that enable scientists to create, share and reuse these templates.
In addition, scientists can create an experimental desktop according to their preferences and work practices.
Other benefits of Openlab ELN include delegation workflows and audit trails, according to Agilent Technologies.
Delegation workflows facilitate enterprise-wide collaboration as multiple scientists can collaborate on a single experiment, entering data and results from multiple techniques on a single sample or multiple samples.
The audit trails maintain an environment that delivers a high level of intellectual property protection.
